A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 96.85
GOOG 594.19
MSFT 44.40
BAC 15.60
FB 75.93

Recently Added

BRK-B 128.39
PSX 82.56
P 27.79
APP 1.07
IEX 79.16

Gaining Speed

BRK-B 128.39
PSX 82.56
IEX 79.16
P 27.79
APP 1.07

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!